Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.

Thumbnail
View/Open
Publication Date
2016-10
ICR Author
Author
Bol, KF
van den Bosch, T
Schreibelt, G
Mensink, HW
Keunen, JEE
Kiliç, E
Japing, WJ
Geul, KW
Westdorp, H
Boudewijns, S
Croockewit, SAJ
van Rossum, MM
de Goede, AL
Naus, NC
van der Graaf, WTA
Gerritsen, WR
de Klein, A
Punt, CJA
Figdor, CG
Cohen, VM
Paridaens, D
de Vries, IJM
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/340
Collections
Version of record
Subject
Dendritic Cells
CD8-Positive T-Lymphocytes
Humans
Melanoma
Uveal Neoplasms
Monophenol Monooxygenase
Cancer Vaccines
Disease-Free Survival
Vaccination
Survival Rate
Adult
Aged
Middle Aged
Female
Male
gp100 Melanoma Antigen
Research team
Clinical and Translational Sarcoma
Language
eng
Date accepted
2016-06-06
License start date
2016-10
Citation
Ophthalmology, 2016, 123 (10), pp. 2265 - 2267